University Health Network- University of Toronto
Welcome,         Profile    Billing    Logout  
 2 Trials 
5 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Lok, Charmaine
PHOSPHATE, NCT03573089: Pragmatic Randomised Trial of High Or Standard PHosphAte Targets in End-stage Kidney Disease

Recruiting
N/A
3600
Europe, Canada, RoW
Liberal phosphate target, Intensive phosphate target
The University of Queensland, National Health and Medical Research Council, Australia, Applied Health Research Centre, Cambridge University Hospitals NHS Foundation Trust, University of Otago
Kidney Failure, Chronic, Hyperphosphatemia
12/27
12/28
NCT04932148: INCremental Dialysis to Improve Health Outcomes in People Starting Haemodialysis (INCH-HD)

Recruiting
N/A
372
Canada, RoW
Incremental HD, Conventional HD
The University of Queensland, Medical Research Future Fund, Queensland Health, Canadian Institutes of Health Research (CIHR)
Kidney Failure
08/26
08/26
Faull, Randall
FALCON, NCT03918447 / 2018-004651-20: A Trial of Bardoxolone Methyl in Patients With ADPKD -

Terminated
3
667
Europe, Japan, US, RoW
Bardoxolone methyl oral capsule, RTA 402, Placebo oral capsule
Reata, a wholly owned subsidiary of Biogen, Reata Pharmaceuticals, Inc., REATA PHARMACEUTICALS, INC
Autosomal Dominant Polycystic Kidney, ADPKD
08/23
08/23
AKTN16.01, NCT04939935: Implementation of Metformin theraPy to Ease Decline of Kidney Function in Polycystic Kidney Disease (IMPEDE-PKD)

Recruiting
3
1174
RoW
Metformin XR, APO-Metformin XR (500mg), Control, Placebo
The University of Queensland
Autosomal Dominant Polycystic Kidney Disease
12/26
05/27
NCT04932148: INCremental Dialysis to Improve Health Outcomes in People Starting Haemodialysis (INCH-HD)

Recruiting
N/A
372
Canada, RoW
Incremental HD, Conventional HD
The University of Queensland, Medical Research Future Fund, Queensland Health, Canadian Institutes of Health Research (CIHR)
Kidney Failure
08/26
08/26

Download Options